常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-3.52/0.20
|
|
企業價值
7.21B
|
| 資產負債 |
|
每股賬面淨值
1.70
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
412.26M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2025/11/16 02:41 EST
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. |

23.85 
